Neuropathological changes in brain cortex and hippocampus in a rat model of Alzheimer's disease

Iranian Biomedical Journal

Volumn 15, Issue 1-2, 2011, Pages 51-58

  Nobakht, Maliheh ^a,b,c   Hoseini, Seyed Mohammad ^c   Mortazavi, Pejman ^c   Sohrabi, Iraj ^c   Esmaeilzade, Banafshe ^a   Rooshandel, Nahid Rahbar ^a   Omidzahir, Shila ^d  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Alzheimer's disease (AD); Hippocampus; Neuropathological changes; amyloid (A )

Indexed keywords

AMYLOID BETA PROTEIN[1-40];

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL LOSS; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; HISTOPATHOLOGY; MALE; MEMORY CONSOLIDATION; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PASSIVE AVOIDANCE; RAT; SUBCORTEX; WHITE MATTER;

RATTUS; RATTUS NORVEGICUS;

EID: 79959909169     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wu, Q.Y., Li, J., Feng, Z.T. and Wang, T.H. (2007) Bone marrow stromal cells of transgenic mice can improve the cognitive ability of an Alzheimer's disease rat model. Neurosci. Lett. 417: 281-285.
2. Markesbery, W.R. and Carney, J.M. (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol. 9: 133-146.
3. Behl, C., Davis, J.B., Lesley, R. and Schubert, D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817-827.
4. Katzman, R. and Saitoh, T. (1991) Advances in Alzheimer's disease. FASEB J. 5: 278-286.
5. Butterfield, D.A. and Stadtman, E.R. (1997) Protein oxidation processes in aging brain. Adv. Cell Aging Gerontol. 2: 161-191.
6. Selkoe, D.J. (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271: 18295-18298.
7. thed, Churchill Livingstone, NY, USA. pp. 779-781.
8. Wevers, A., Witter, B., Moser, N., Burghaus, L., Banerjee, C., Steinlein, O.K., Schutz, U., de Vos, R.A., Steur, E.N., Lindstrom, J. and Schroder, H. (2000) Classical Alzheimer features and cholinergic dysfunction: Towards a unifying hypothesis? Acta Neurol. Scand. Suppl. 176: 42-48.
9. Perry, E.K., Perry, R.H., Blessed, G. and Tomlinson, B.E. (1977) Necropsy evidence of central cholinergic deficits in senile dementia [letter]. Lancet 1: 189.
10. Whitehouse, P.J., Price, D.L., Clark, A.W., Coyle, J.T. and De Long, M.R. (1981) Alzheimer's disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10:122-126.
11. thed., Saunders, New York, USA. pp. 1313-1319.
12. López-Toledano, M.A. and Shelanski, M.L.
13. López-Toledano, M. A*Shelanski, M.L. (2004) Neurogenic Effect of β-Amyloid Peptide in the Development of Neural Stem Cells. J. Neuroscience 24 (23): 5439-5444.
14. Selkoe, D.J. (1997) The molecular pathology of Alzheimer's disease. Neuron 16: 487-498.
15. Hyman, B.T., Van Hoesen, G.W., Damasio, A.R. and Barnes, C.L. (1984) Alzheimer's disease: CellspeciWc pathology isolates the hippocampal formation. Science 225: 1168-1170.
16. Wallenstein, G.V.H. and Hasselmo, M.E. (1998) The hippocampus as an associator of discontinuous events. Trends Neurosci. 21: 317-323.
17. Bures, J., Buresová, O. and Huston, J.P. (1983) Techniques and basic experiments for the study of brain and behavior. Elsevier Academic Publishers, Netherlands.
18. Bursztajn, S.H., DeSouza, R., McPhie, D.L., Berman, S.A., Shioi, J., Robakis, N.K. and Neve, R.L. (1998) Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis. J. Neuroscience. 18: 9790-9799.
19. Verbeek MM, Vinters H, and de Waal RM. (2000). Cerebrovascular Amyloidosis in Alzheimer's Disease and Related Disorders. Amsterdam: Kluwer, In press.
20. Roghani, M., Joghataie, M.T., Jalali, M.R. and Baluchnejadmojarad, T. (2006) Time course of changes in passive avoidance and Y-maze performance in male diabetic rats. Iran. Biomed. J. 10: 99-104.
21. Kowall, N.W., Beal, M.F., Busciglio, J., Duffy, L.K., Yankner, B.A. (1991) An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance. Proc. Natl. Acad. Sci. 88: 7247-7251.
22. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501.
23. Bennett, M.W., O'Connell J., O'Sullivan, G.C., Roche, D., Brady, C., Kelly, J., Collins, J.K. and Shanahan, F. (1999) Expression of Fas ligand by human gastric adenocarcinomas: A potential mechanism of immune escape in stomach cancer. Gut. 44:156-162.
24. Sahgal A. (1993) Passive avoidance procedure. In: Sahgal A, ed. Behavioral Neuroscience: Volume 1: A Practical Approach. Oxford, England: IRL Press; 49-56.
25. Shimizu-Sasamata, M., Yamamoto, M., Okada, M., Yamaguchi, T. and Tamura, A. (1992) Effects of indeloxazine hydrochloride on behavioral and biochemical changes in chronic phase of focal cerebral ischemia in rats. Arch. Int. Pharmacodyn. Ther. 314: 74-89.
26. Jacqueline, N.C. (2000) Learning and Memory What's wrong with my mouse? WLLET-LISS, Canada. p. 99.
27. Kaoud, H.A., Kamel, M.M., Abdel-Razek, A.H., Kamel, G.M. and Ahmed, K.A. (2010) Neurobehavioural, neurochemical and neuromorphological effects of cadmium in male rats. J. Am. Sci. 6: 189-202.
28. Hashimoto, M., Hossain, S., Shimada, T., Sugioka, K., Yamasaki, H., Fujii, Y., Ishibashi, Y., Oka, J. and Shido, O. (2002) Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J. Neurochem. 81: 1084-1091.
29. Shirai, N. and Suzuki, H. (2004) Effect of dietary docasahexaenoic acid and catechins on maze behavior in mice. Ann. Nutr. Metab. 48: 51-58.
30. Nobakht, M., Najafzadeh N. and Kordestani Shargh B. (2009) Effects of tamoxifen on morphological and ultrastructural aspects of developing hippocampus of rat. Iran. Biomed. J. 13: 237-243.
31. Stephan, A., Laroche, S. and Davis, S. (2001) Generation of aggregated β-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci. 21: 5703-5714.
32. Koudinov, A.R., Berezov, T.T. and Koudinova, N.V. (2001) Amyloid plaque (and not diffuse amyloid) is a condition for neuronal dysfunction. Clin. Med. Health Res.:9-16.
33. Li, Y., Chopp, M., Chen, J., Wang, L., Gautam, S.C., Xu, Y.X. and Zhang, Z. (2000) Intrastriatal transplantation of bone marrow nonhomatopoietic cells improves functional recovery after stroke in adult mice. J. Cereb. Blood Flow Metab. 20: 1311-1319.
34. Guo, Q, Fu, W., Xie, J., Luo, H., Sells, S.F., Geddes, J.W., Bondada, V., Rangnekar, V.M. and Mattson, M.P. (1998) Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat. Med. 4: 957-962.
35. Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K. and Wisniewski H.M. (1995) Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89: 35-41.
36. Hyman, B.T., Marzloff, K. and Arriagada P.V. (1993) The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J. Neuropathol. Exp. Neurol. 52: 594-600.
37. Cummings, B.J. and Cotman C.W. (1995) Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet 346: 1524-1528.
38. Terry, R.D. (1996). The pathogenesis of Alzheimer disease: An alternative to the amyloid hypothesis. J. Neuropathol. Exp. Neurol. 55: 1023-1025.